结核与肺部疾病杂志 ›› 2022, Vol. 3 ›› Issue (6): 501-505.doi: 10.19983/j.issn.2096-8493.20220138

• 论著 • 上一篇    下一篇

腹腔积液结核感染T细胞斑点试验不同阈值在结核性腹膜炎中的诊断价值

石海萍(), 仵倩红   

  1. 陕西省结核病防治院,西安 710100
  • 收稿日期:2022-08-25 出版日期:2022-12-20 发布日期:2022-12-15
  • 通信作者: 石海萍 E-mail:834844945@qq.com
  • 基金资助:
    陕西省卫生健康委科研基金(D2018046)

The diagnostic value of different thresholds for T cell spot test with peritoneal effusion tuberculosis in tuberculous peritonitis

Shi Haiping(), Wu Qianhong   

  1. Shaanxi Provincial Hospital of Tuberculosis Prevention and Treatment, Xi’an 710100, China
  • Received:2022-08-25 Online:2022-12-20 Published:2022-12-15
  • Contact: Shi Haiping E-mail:834844945@qq.com
  • Supported by:
    Shaanxi Provincial Health and Health Scientific Research Fund Project(D2018046)

摘要:

目的: 探讨腹腔积液结核感染T细胞斑点试验(T-SPOT.TB)不同阈值在结核性腹膜炎中的诊断价值。方法: 选取陕西省结核病防治院2016年1月至2020年12月期间48例确诊的腹腔积液患者作为研究对象,所有患者均在超声引导下进行了腹腔穿刺术及腹膜组织活检术,同时行外周血T-SPOT.TB、腹腔积液T-SPOT.TB、腹腔积液结核分枝杆菌涂片、腹腔积液BACTEC MGIT 960液体培养(MGIT 960液体培养)、腹腔积液分子生物学检查、腹膜组织病理检查及分子生物学检查。以临床复合标准作为参考,评价外周血T-SPOT.TB、腹腔积液T-SPOT.TB(分别设定6SFC/106、30SFC/106为阳性阈值)在结核性腹膜炎诊断中的敏感度、特异度、符合率及一致性。结果: 48例患者中,31例确诊为结核性腹膜炎,其中3例经腹腔积液抗酸染色阳性确诊,11例经MGIT 960液体培养阳性确诊,13例经腹腔积液或腹膜组织分子生物学检查阳性确诊,2例经腹膜组织病理为肉芽肿伴干酪样坏死确诊,2例经腹膜组织病理为肉芽肿性炎,经抗结核治疗2个月有效后确诊。17例确诊为非结核性腹膜炎,其中恶性腹腔积液13例,细菌性腹腔积液2例,红斑狼疮1例,淋巴瘤1例;4例经腹腔积液病理确诊,11例经腹膜组织病理确诊,2例经腹腔积液细菌培养确诊。以临床复合标准作为参考标准,外周血T-SPOT.TB腹腔积液T-SPOT.TB.数值分别以6SFC/106、30SFC/106作为阳性阈值,3种检测方法在结核性腹膜炎中诊断的敏感度分别为83.9%(95%CI:65.5%~93.9%)、87.1%(95%CI:69.2%~95.8%)、83.9%(95%CI:65.5%~93.9%),特异度分别为76.5%(95%CI:48.8%~92.2%)、82.4%(95%CI:55.8%~95.3%)、94.1%(95%CI:69.2%~99.7%),符合率分别为81.2%(95%CI:68.7%~92.1%)、85.4%(95%CI:66.8%~97.2%)、87.5%(95%CI:72.1%~98.4%),Kappa值分别为0.596、0.685、0.778。结论: 以临床复合标准作为参考标准,腹腔积液中设定不同T-SPOT.TB阳性阈值对结核性腹膜炎的诊断效能不同,将阳性阈值由6SFC/106提升到30SFC/106,诊断效能明显提升。

关键词: 腹膜炎, 结核性, 免疫学试验, 对比研究

Abstract:

Objective: To investigate the diagnostic value of T cell spot test (T-SPOT. TB) with different thresholds in tuberculosis peritonitis. Methods: From January 2016 to December 2020, 48 patients with abdominal effusion diagnosed in Shaanxi Provincial Hospital of Tuberculosis Prevention and treatment were selected as the research objects. All patients underwent intraperitoneocentesis and peritoneal tissue biopsy under ultrasound guidance. At the same time, peripheral blood T-SPOT.TB, abdominal fluid effusion T-SPOT.TB, peritoneal fluid effusion Mycobacterium tuberculosis smear, peritoneal fluid effusion BACTEC MGIT 960 fluid culture (MGIT 960 liquid culture), peritoneal fluid molecular biology examination, peritoneal histopathological examination and molecular biology examination were performed. Final clinical composite criteria were used as a reference. The sensitivity, specificity, compliance rate and consistency of peripheral blood T-SPOT.TB and abdominal effusion T-SPOT.TB (setting 6 SFC/106 and 30 SFC/106, respectively) were evaluated in tuberculous peritonitis. Results: Of the 48 patients, 31 were definitely diagnosed as tuberculous peritonitis, 3 were confirmed by positive antiacid staining of abdominal effusion, 11 were confirmed by positive MGIT 960 liquid culture medium, 13 were confirmed by positive molecular biological tests of peritoneal effusion or peritoneal tissue, 2 were confirmed as granuloma of peritoneal tissue with caseous necrosis, 2 were confirmed as granulomatous inflammation of peritoneal tissue after effective anti-tuberculosis therapy for 2 months. 17 were definitely diagnosed as non-tuberculous peritonitis, with 13 malignant ascites, 2 bacterial ascites, 1 lupus erythematosus, 1 lymphoma lymphoma. Four were diagnosed by pathology ascites, athological diagnosis, 11 by peritoneal histopathology, and 2 by bacterial culture of ascites. Clinical composite standard was used as the reference standard. We choose 6 SFC/106 for peripheral blood T-SPOT.TB, and 30 SFC/106 for peritoneal effusion T-SPOT.TB as positive thresholds, respectively. The sensitivity of the three assays tested in tuberculous peritonitis were 83.9% (95%CI:65.5%-93.9%), 87.1% (95%CI:69.2%-95.8%) and 83.9% (95%CI:65.5%-93.9%), and the specificity were 76.5% (95%CI:48.8%-92.2%), 82.4% (95%CI:55.8%-95.3%) and 94.1% (95%CI:69.2%-99.7%), with the conformance rate of 81.2% (95%CI:68.7%-92.1%), 85.4% (95%CI:66.8%-97.2%) and 87.5%(95%CI:72.1%-98.4%), and the Kappa values of 0.596, 0.685 and 0.778, respectively. Conclusion: With the clinical composite standard as the reference standard, setting different positive T-SPOT.TB threshold values in abdominal effusion might change the diagnostic efficacy of tuberculosis peritonitis, and raising the positive threshold from 6 SFC/106 to 30 SFC/106 might enhance its diagnostic efficacy.

Key words: Peritonitis, tuberculous, Immunologic tests, Comparative study

中图分类号: